The pharmacokinetics of dapsone after oral administration to healthy volunteers.
Open Access
- 1 October 1986
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 22 (4) , 491-494
- https://doi.org/10.1111/j.1365-2125.1986.tb02924.x
Abstract
After oral administration of 100 mg dapsone (DDS) to 25 healthy volunteers peak serum DDS concentrations between 1.10 and 2.33 mg l‐1 were reached within 0.5 to 4 h. AUCs varied from 20.3 to 75.4 mg l‐1 h, while the elimination half‐lives ranged from 11.5 to 29.2 h. The apparent volumes of distribution were 0.84 to 1.26 l kg‐1 body weight, assuming complete bioavailability. Statistically significant differences in peak drug concentration, peak time and AUC existed between males and females. Absorption and elimination of DDS appeared to be faster than reported in other studies, suggesting differences in DDS kinetics between healthy volunteers and patients.This publication has 12 references indexed in Scilit:
- A rapid method for determination of acetylation phenotype using dapsone.British Journal of Clinical Pharmacology, 1984
- Pharmacokinetic observations on dapsone in dermatitis herpetiformisBritish Journal of Dermatology, 1983
- Dapsone in Saliva and Plasma of ManPharmacology, 1981
- Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.British Journal of Clinical Pharmacology, 1980
- Oral activated charcoal and dapsone eliminationClinical Pharmacology & Therapeutics, 1980
- Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic methodEuropean Journal of Clinical Pharmacology, 1980
- N-hydroxylation of 4,4?-diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humansNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- The polymorphic acetylation of dapsone in manClinical Pharmacology & Therapeutics, 1971
- ABSORPTION AND EXCRETION OF 35S DAPSONE IN DERMATITIS HERPETIFORMISBritish Journal of Dermatology, 1970